Phase I Dose Escalation Study of Recombinant Interleukin-21 (Ril-21; Bms-982470) in Combination with Nivolumab (Anti-Pd-1; Bms-936558; Ono-4538) in Patients (pts) with Advanced or Metastatic Solid Tumors
Journal of clinical oncology(2013)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要